157 related articles for article (PubMed ID: 3116919)
1. Biological activity of BO-1236, a new antipseudomonal cephalosporin.
Nakagawa S; Sanada M; Matsuda K; Hazumi N; Tanaka N
Antimicrob Agents Chemother; 1987 Jul; 31(7):1100-5. PubMed ID: 3116919
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin.
Nakagawa S; Sanada M; Matsuda K; Hashizume T; Asahi Y; Ushijima R; Ohtake N; Tanaka N
Antimicrob Agents Chemother; 1989 Sep; 33(9):1423-7. PubMed ID: 2510590
[TBL] [Abstract][Full Text] [Related]
3. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.
Fung-Tomc J; Dougherty TJ; DeOrio FJ; Simich-Jacobson V; Kessler RE
Antimicrob Agents Chemother; 1989 Apr; 33(4):498-502. PubMed ID: 2499250
[TBL] [Abstract][Full Text] [Related]
4. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
5. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
van Klingeren B
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
Chin NX; Zhang YX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(5):417-24. PubMed ID: 1797456
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
Fuchs PC; Jones RN; Barry AL; Thornsberry C
Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of BMY-28142, a new cephalosporin.
Norden CW; Neiderriter K
Chemotherapy; 1987; 33(1):15-7. PubMed ID: 3103990
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
Neu HC
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175
[TBL] [Abstract][Full Text] [Related]
11. In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.
Katsu K; Kitoh K; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1982 Aug; 22(2):181-5. PubMed ID: 6100421
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
[TBL] [Abstract][Full Text] [Related]
13. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Acred P; Ryan DM; Sowa MA; Watts CM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
[TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo antibacterial activities of E1040, a new cephalosporin with potent antipseudomonal activity.
Hiruma R; Otsuki M; Tashima M; Obana Y; Nishino T
J Antimicrob Chemother; 1990 Dec; 26(6):769-81. PubMed ID: 2127928
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamases.
Livermore DM; Williams RJ; Williams JD
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():163-7. PubMed ID: 19802980
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Norris SM; Guenthner SH; Wenzel RP
J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin.
Tomatsu K; Ando S; Masuyoshi S; Hirano M; Miyaki T; Kawaguchi H
J Antibiot (Tokyo); 1986 Nov; 39(11):1584-91. PubMed ID: 3539901
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
Kessler RE; Bies M; Buck RE; Chisholm DR; Pursiano TA; Tsai YH; Misiek M; Price KE; Leitner F
Antimicrob Agents Chemother; 1985 Feb; 27(2):207-16. PubMed ID: 3885849
[TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activity of KP-736, a new cephem antibiotic.
Maejima T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964
[TBL] [Abstract][Full Text] [Related]
20. Activity of cefepime against ceftazidime-resistant gram-negative bacilli using low and high inocula.
Johnson CC; Livornese L; Gold MJ; Pitsakis PG; Taylor S; Levison ME
J Antimicrob Chemother; 1995 Jun; 35(6):765-73. PubMed ID: 7559188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
